Abstract:Background: Many preclinical studies have demonstrated the effectiveness of genetically modified probiotics (gm probiotics) in animal models of inflammatory bowel disease (IBD). Objective: This systematic review was performed to investigate the role of gm probiotics in treating IBD and to clarify the involved mechanisms. Methods: PubMed, Web of Science, Cochrane Library, and Medline were searched from their inception to 18 September 2022 to identify preclinical and clinical studies exploring the efficacy of gm probiotics in IBD animal models or IBD patients. Two independent researchers extracted data from the included studies, and the data were pooled by the type of study; that is, preclinical or clinical. Results: Forty-five preclinical studies were included. In these studies, sodium dextran sulfate and trinitrobenzene sulfonic acid were used to induce colitis. Eleven probiotic species have been genetically modified to produce therapeutic substances, including IL-10, antimicrobial peptides, antioxidant enzymes, and short-chain fatty acids, with potential therapeutic properties against colitis. The results showed generally positive effects of gm probiotics in reducing disease activity and ameliorating intestinal damage in IBD models; however, the efficacy of gm probiotics compared to that of wild-type probiotics in many studies was unclear. The main mechanisms identified include modulation of the diversity and composition of the gut microbiota, production of regulatory metabolites by beneficial bacteria, reduction of the pro- to anti-inflammatory cytokine ratio in colonic tissue and plasma, modulation of oxidative stress activity in the colon, and improvement of intestinal barrier integrity. Moreover, only one clinical trial with 10 patients with Crohn's disease was included, which showed that L. lactis producing IL-10 was safe, and a decrease in disease activity was observed in these patients. Conclusions: Gm probiotics have a certain efficacy in colitis models through several mechanisms. However, given the scarcity of clinical trials, it is important for researchers to pay more attention to gm probiotics that are more effective and safer than wild-type probiotics to facilitate further clinical translation.

The single-cell modification strategies for probiotics delivery in inflammatory bowel disease: A review

Recent advances in the design and fabrication of probiotic delivery systems to target intestinal inflammation

Design of probiotic delivery systems and their therapeutic effects on targeted tissues

Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease—An Overview

From probiotic chassis to modification strategies, control and improvement of genetically engineered probiotics for inflammatory bowel disease

Oral delivery of probiotics using single-cell encapsulation

Colon Targeted Delivery Dosage Forms for Probiotics: A Review

Oral responsive delivery systems for probiotics targeting the intestinal tract

Dual-layer probiotic encapsulation using metal phenolic network with gellan gum-tamarind gum coating for colitis treatment

Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease

Microfluidics-Derived Microparticles with Prebiotics and Probiotics for Enhanced in Situ Colonization and Immunoregulation of Colitis.

Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease

The Effect of Probiotics on Treatments in Patients Affected by Inflammatory Bowel Disease: A Systematic Review

The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review

Postbiotics in inflammatory bowel disease: efficacy, mechanism, and therapeutic implications

Recent Advances in Bacteria‐based Platforms for Inflammatory Bowel Diseases Treatment

Research progress of probiotics and their protective strategy in the field of inflammatory bowel disease treatment: A review

Design of probiotic delivery systems for targeted release

Tapping the Potential of Probiotics: An Insight on Probiotic Delivery Systems, Their Quantification, and Assessment

Progress in microencapsulation of probiotics: A review

Precise oral delivery systems for probiotics: A review